Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with Mannheimia (Pasteurella) haemolytica.
about
Pharmacodynamics of antimicrobials against Mycoplasma mycoides mycoides small colony, the causative agent of contagious bovine pleuropneumoniaDetermination of the duration of antibacterial efficacy following administration of gamithromycin using a bovine Mannheimia haemolytica challenge modelImpact of Timing and Dosage of a Fluoroquinolone Treatment on the Microbiological, Pathological, and Clinical Outcomes of Calves Challenged with Mannheimia haemolytica.Influence of systemic fluoroquinolone administration on the presence of Pasteurella multocida in the upper respiratory tract of clinically healthy calves.Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids.Estimating danofloxacin withdrawal time in broiler chickens based on physiologically based pharmacokinetics modeling.Pharmacokinetics and distribution in interstitial and pulmonary epithelial lining fluid of danofloxacin in ruminant and preruminant calves.Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in calves.Efficacy of difloxacin against respiratory infections of lambs.Pharmacokinetics of danofloxacin andN-desmethyldanofloxacin in adult horses and their concentration in synovial fluidPharmacokinetic/Pharmacodynamic Integration to Evaluate the Changes in Susceptibility of After Repeated Administration of DanofloxacinA Supramolecular Approach for Enhanced Antibacterial Activity and Extended Shelf-life of Fluoroquinolone Drugs with Cucurbit[7]uril
P2860
Q28482671-0493E4F2-898F-4C69-86CB-03025594C629Q34529251-A6387291-6BDF-4CC7-9CDD-E189C27B0D52Q36637193-179D4AE8-95A6-4B4A-A4B9-D49708B2C3FBQ36916081-83B40449-4014-4423-946A-BC7F8937AF91Q39740646-EA4F88FD-AC0C-4A95-B6CE-B6D8D07CDB0EQ41733511-AB9D5A18-55B5-4B79-9DBF-25D287D6A252Q44865829-CD2E175C-3037-45C4-87F0-9491A2BEAEDDQ46518946-8C01313B-7276-49AA-85AD-4DEE77698833Q46543614-6BD04076-5CC2-47CE-A4F2-12A7C1AF23F6Q57438066-346AAAE3-76E0-4E9B-B0ED-48B1D96DF9DDQ58123039-94232A24-B1D0-404C-8BE4-F877E0899328Q58733861-EAB273C7-0FD8-4380-A0C1-CFF796F08C4A
P2860
Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with Mannheimia (Pasteurella) haemolytica.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pharmacokinetic and pharmacody ...... mia (Pasteurella) haemolytica.
@ast
Pharmacokinetic and pharmacody ...... mia (Pasteurella) haemolytica.
@en
Pharmacokinetic and pharmacody ...... alves infected with Mannheimia
@nl
type
label
Pharmacokinetic and pharmacody ...... mia (Pasteurella) haemolytica.
@ast
Pharmacokinetic and pharmacody ...... mia (Pasteurella) haemolytica.
@en
Pharmacokinetic and pharmacody ...... alves infected with Mannheimia
@nl
prefLabel
Pharmacokinetic and pharmacody ...... mia (Pasteurella) haemolytica.
@ast
Pharmacokinetic and pharmacody ...... mia (Pasteurella) haemolytica.
@en
Pharmacokinetic and pharmacody ...... alves infected with Mannheimia
@nl
P2093
P2860
P1476
Pharmacokinetic and pharmacody ...... mia (Pasteurella) haemolytica.
@en
P2093
Fariborz Shojaee AliAbadi
Kate A Marr
Patxi Sarasola
Peter Lees
Quintin A McKellar
Simon J Sunderland
Tim G Rowan
William Donachie
P2860
P304
P356
10.1128/AAC.46.9.3013-3019.2002
P407
P577
2002-09-01T00:00:00Z